Skip to content

The Effect of Adhesiolysis During Elective Abdominal Surgery on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs

A Prospective Study on the Effect of Adhesiolysis During Elective Laparotomy or Laparoscopy on Per- and Postoperative Complication, Quality of Life and Socioeconomic Costs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01236625
Acronym
LAPAD
Enrollment
752
Registered
2010-11-08
Start date
2008-06-30
Completion date
2011-02-28
Last updated
2012-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tissue Adhesions

Keywords

Tissue Adhesions, Adhesiolysis, Inadvertent enterotomy, Prospective cohort study, Quality of life

Brief summary

Official title: LAPAD - A prospective study on the effect of adhesiolysis during elective laparotomy or laparoscopy on per- and postoperative complication, quality of life and socioeconomic costs Background: With improved surgical technology and ageing of the population the number of reoperations in the abdomen dramatically increases. The risk for a repeat laparotomy or laparoscopy is a high as 30% in the first ten years after a laparotomy. In over 95% of reoperations adhesiolysis is required to gain access to the abdominal cavity and operation area. Adhesiolysis significantly increases the risk for inadvertent organ damage, such as enterotomies, leading to higher morbidity, mortality and socioeconomic costs. Purpose: To define the impact of adhesiolysis on per- and postoperative complications, quality of life and socioeconomic costs. Design: Prospective observational study. Primary outcomes: * adhesiolysis time * inadvertent enterotomy * seromuscular injury * miscellaneous organ damage * Serious adverse events of operation (anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death) Secondary outcomes: * Hospital stay * Intensive care admission * Reinterventions * In-hospital costs * Parenteral feeding * Short term readmissions (30 days) * Quality of life (Gastro- intestinal tract complaints, Short Form- 36(SF-36), DASI (Duke Activity Score Index(DASI) ) Estimated enrollment: 800 start study: 1 june 2008 Inclusion completion date: 1 june 2010 Estimated study completion date: 1 february 2011

Interventions

PROCEDUREAdhesiolysis

Blunt or sharp dissection of adhesive tissue.

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Planned elective laparotomy or laparoscopy * Mentally competent * 18 years or older

Exclusion criteria

* Operation cancelled * Bad quality of data

Design outcomes

Primary

MeasureTime frameDescription
Inadvertent EnterotomyDay of surgery (one day)Every unintended and iatrogenic full thickness defect of the bowel.
Seromuscular InjuryDay of surgery (one day)Every visible damage to the serosa, without leakage or exposure of the bowel lumen.
Miscellaneous Organ DamageDay of surgery (one day)Unintended iatrogenic damage to intra- peritoneal organs and structures other than bowel. E.g. Spleen, liver, pancreas or ureter.
Serious Adverse Events30 daysComplications marked as SAE: anastomotic leakage, delayed diagnosed perforation, wound infection, abdominal infection, haemorrhage, pneumonia, urinary tract infection, abscess, fistula, sepsis, death
Adhesiolysis TimeDay of surgery (one day)Time required to dissect adhesive tissue.

Secondary

MeasureTime frameDescription
Hospital stayFrom surgery to dischargeNumber of days from surgery until discharge
Reinterventions30 days after dischargeEmergency reoperation related to a complication of initial surgery within max. 30 days after discharge.
In- hospital CostsFrom surgery to dischargeDirect costs comprising costs from operation, stay on ward and Intesive Care Unit, medication use, diagnostics.
Parenteral FeedingFrom surgery to dischargeNumber of days that patient required parenteral feeding.
Short term readmissions30 days after dischargeReadmissions to the hospital related to complication of surgery.
Quality of life6 months post surgeryQuality of life as measured with SF-36, Gastro- intestinal tract complaints and DASI index.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026